| Autor: |
Uffer M; Service d'urologie, CHUV, Lausanne. Matieu.Uffer@chuv.ch, Chollet Y, Cardinaux C, Erling C, Praz V, Ramadani D, Tawadros T, Treutherdt C, Wisard M, Zarkik Y, Jichlinski P |
| Jazyk: |
francouzština |
| Zdroj: |
Revue medicale suisse [Rev Med Suisse] 2008 Jan 16; Vol. 4 (140), pp. 166-8. |
| Abstrakt: |
The systemic treatment of kidney cancers is promising regarding the first results of the inhibiting molecules of the angiogenesis. Projections in research are encouraging for more specific and sensitive markers of the prostate cancer. For this last the intermittent hormonotherapy improves the quality of life of the patients. The overweight control in infertility allows greater chances of giving birth. The morbidity of the kidney percutaneous surgery is decreased by the use of smaller tools. Reduction rate of reobstruction thanks to new manufactoring stents. The botulinic toxin for the hyperactive bladder refunded by the health insurances. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
